Robert M. Langdon
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
- Vascular Tumors and Angiosarcomas 2
- Co-authors
- Thomas J. SmithDeborah SchragNeal J. MeropolPeter A. UbelLowell E. SchnipperDiane BlumTherese M. MulveyJamés O. Armitage
- Journals
- Journal of Clinical Oncology (8 papers)Cancer (2 papers)Clinical Cancer Research (2 papers)Journal of Thoracic Oncology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesItalyRussia
In The Last Decade
Robert M. Langdon
27 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 739
- Hematology 215
- Genetics 142
- Economics and Econometrics 343
- Pulmonary and Respiratory Medicine 305
Countries citing papers authored by Robert M. Langdon
This map shows the geographic impact of Robert M. Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Langdon more than expected).
Fields of papers citing papers by Robert M. Langdon
This network shows the impact of papers produced by Robert M. Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Langdon. The network helps show where Robert M. Langdon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert M. Langdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2020 | 116 | |
| 3 | 2019 | 1 | |
| 4 | 2019 | 41 | |
| 5 | 2018 | 6 | |
| 6 | 2018 | 43 | |
| 7 | 2015 | 73 | |
| 8 | 2013 | 22 | |
| 9 | 2012 | 1 | |
| 10 | 2012 | 4 | |
| 11 | 2011 | 2 | |
| 12 | 2006 | 48 | |
| 13 | 2005 | 113 | |
| 14 | 1995 | 170 | |
| 15 | 1995 | 10 | |
| 16 | 1993 | 3 | |
| 17 | 1989 | 44 | |
| 18 | 1985 | 179 | |
| 19 | 1957 | 0 | |
| 20 | American foreign policy | 1954 | 3 |
About Robert M. Langdon
Robert M. Langdon is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Epidemiology and Gastroenterology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pituitary Gland Disorders and Treatments (3 papers), Gastric Cancer Management and Outcomes (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Oncology (739 citations), Hematology (215 citations), Genetics (142 citations), Economics and Econometrics (343 citations) and Pulmonary and Respiratory Medicine (305 citations). Robert M. Langdon has collaborated with scholars based in United States, Italy and Russia. Frequent co-authors include Thomas J. Smith, Deborah Schrag, Neal J. Meropol, Peter A. Ubel, Lowell E. Schnipper, Diane Blum, Therese M. Mulvey, Jamés O. Armitage, Kathy Foucar and Thomas J. Carroll. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.